Literature DB >> 10900158

Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.

M Vihinen1, A Villa, P Mella, R F Schumacher, G Savoldi, J J O'Shea, F Candotti, L D Notarangelo.   

Abstract

Hereditary severe combined immunodeficiency (SCID) includes a heterogeneous group of diseases that profoundly affect both cellular and humoral immune responses and require treatment by bone marrow transplantation. Characterization of the cellular and molecular bases of SCID is essential to provide accurate genetic counseling and prenatal diagnosis, and it may offer the grounds for alternative forms of treatment. The Jak3 gene is mutated in most cases of autosomal recessive T(-)B(+) SCID in humans. Jak3 belongs to the family of intracellular Janus tyrosine kinases. It is physically and functionally coupled to the common gamma chain, gammac, shared by several cytokine receptors. We have established the JAK3base registry for disease and mutation information. In order to study the structural consequences of the Jak3 mutations, the structure of the human Jak3 kinase and pseudokinase domains was modeled. Residues involved in ATP and Mg(2+) binding were highly conserved in the kinase domain whereas the substrate binding region is somewhat different compared to other kinases. We have identified the first naturally occurring mutations disrupting the function of the human Jak3 kinase domain. The structural basis of all of the known Jak3 mutations reported so far is discussed based on the modeled structure. The model of the Jak3 protein also permits us to study Jak3 phosphorylation at the structural level and may thus serve in the design of novel immune suppressive drugs. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900158     DOI: 10.1006/clim.2000.4880

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

1.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Authors:  Stella George; Justin J Rochford; Christian Wolfrum; Sarah L Gray; Sven Schinner; Jenny C Wilson; Maria A Soos; Peter R Murgatroyd; Rachel M Williams; Carlo L Acerini; David B Dunger; David Barford; A Margot Umpleby; Nicholas J Wareham; Huw Alban Davies; Alan J Schafer; Markus Stoffel; Stephen O'Rahilly; Inês Barroso
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

3.  A Novel Homozygous JAK3 Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.

Authors:  Lucila A Barreiros; Gesmar R S Segundo; Anete S Grumach; Pérsio Roxo-Júnior; Troy R Torgerson; Hans D Ochs; Antonio Condino-Neto
Journal:  Front Pediatr       Date:  2018-08-20       Impact factor: 3.418

4.  Whole-exome sequencing of T- B+ severe combined immunodeficiency in Egyptian infants, JAK3 predominance and novel variants.

Authors:  R El Hawary; S Meshaal; J Pachlopnik Schmid; A Elmarsafy; A A Mauracher; L Opitz; D Abd Elaziz; S Lotfy; A Eldash; J Boutros; N Galal
Journal:  Clin Exp Immunol       Date:  2020-11-02       Impact factor: 5.732

5.  Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3.

Authors:  Sol A Ban; Elisabeth Salzer; Martha M Eibl; Angela Linder; Christoph B Geier; Elisangela Santos-Valente; Wojciech Garncarz; Thomas Lion; Raphael Ott; Christoph Seelbach; Kaan Boztug; Hermann M Wolf
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

6.  Crystal Structure of the FERM-SH2 Module of Human Jak2.

Authors:  Randall McNally; Angela V Toms; Michael J Eck
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.